| 臺大學術典藏 |
2022-02-23T02:12:45Z |
Intra-abdominal myxofibrosarcoma with liver surface compression mimicking intrahepatic tumors on abdominal ultrasound
|
Kuo Y.-N.; .CHIEN-HUNG CHEN; Huang G.-T.; Lee H.-S.; Yu S.-C.; Sheu J.-C. |
| 臺大學術典藏 |
2022-02-23T02:12:43Z |
Deletion mapping of chromosome 16q24 in hepatocellular carcinoma in Taiwan and mutational analysis of the 17-β-HSD gene localized to the region
|
Lin Y.-W.; Lee I.-N.; CHIEN-HUNG CHEN; Huang G.-T.; Lee H.-S.; Lee P.-H.; Lu F.-J.; Sheu J.-C. |
| 臺大學術典藏 |
2022-02-23T02:12:43Z |
Expressions of cancer-testis antigens in human hepatocellular carcinomas
|
CHIEN-HUNG CHEN; Chen G.-J.; Lee H.-S.; Huang G.-T.; Yang P.-M.; Tsai L.-J.; Chen D.-S.; Sheu J.-C. |
| 臺大學術典藏 |
2022-02-23T02:12:43Z |
Expression of matrix metalloproteinases in spontaneous regression of liver fibrosis
|
Lee H.-S.; Huang G.-T.; Miau L.-H.; Chiou L.-L.; CHIEN-HUNG CHEN; Sheu J.-C. |
| 臺大學術典藏 |
2022-02-23T02:12:42Z |
Less reversal of liver fibrosis after prolonged carbon tetrachloride injection
|
Lee H.-S.; Huang G.-T.; CHIEN-HUNG CHEN; Chiou L.-L.; Lee C.-C.; Yang P.-M.; Chen D.-S.; Sheu J.-C. |
| 臺大學術典藏 |
2022-02-23T02:12:41Z |
Percutaneous microwave coagulation therapy under ultrasound guidance for small hepatocellular carcinoma.
|
Liang J.D.; Yang P.M.; Huang G.T.; Lee H.S.; CHIEN-HUNG CHEN; Liang P.C.; Sheu J.C.; Chen D.S. |
| 臺大學術典藏 |
2022-02-23T02:12:41Z |
Differential role of p38 in IL-1α induction of MMP-9 and MMP-13 in an established liver myofibroblast cell line
|
Lee H.-S.; Miau L.-H.; CHIEN-HUNG CHEN; Chiou L.-L.; Huang G.-T.; Yang P.-M.; Sheu J.-C. |
| 臺大學術典藏 |
2022-02-23T02:12:40Z |
Clonality analysis of multiple hepatocellular carcinomas by loss of heterozygosity pattern determined by chromosomes 16q and 13q
|
Lin Y.-W.; Lee H.-S.; CHIEN-HUNG CHEN; Huang G.-T.; Lee P.-H.; Sheu J.-C. |
| 臺大學術典藏 |
2022-02-23T02:12:40Z |
The role of transcatheter arterial embolization in patients with resectable hepatocellular carcinoma: A nation-wide, multicenter study
|
Huang Y.-H.; CHIEN-HUNG CHEN; Chang T.-T.; Chen S.-C.; Wang S.-Y.; Lee P.-C.; Lee H.-S.; Lin P.-W.; Huang G.-T.; Sheu J.-C.; Tsai H.-M.; Chau G.-Y.; Chiang J.-H.; Liu W.-Y.; Lee S.-D.; Wu J.-W. |
| 臺大學術典藏 |
2022-02-23T02:12:40Z |
Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery
|
Huang Y.-H.; CHIEN-HUNG CHEN; Chang T.-T.; Chen S.-C.; Wang S.-Y.; Lee H.-S.; Lin P.-W.; Huang G.-T.; Sheu J.-C.; Tsai H.-M.; Lee P.-C.; Chau G.-Y.; Lui W.-Y.; Lee S.-D.; Wu J.-C. |
| 臺大學術典藏 |
2022-02-23T02:12:39Z |
Hydroxyproline content of needle biopsies as an objective measure of liver fibrosis: Emphasis on sampling variability
|
Lee H.-S.; Shun C.-T.; Chiou L.-L.; CHIEN-HUNG CHEN; Huang G.-T.; Sheu J.-C. |
| 臺大學術典藏 |
2022-02-23T02:12:39Z |
Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry
|
Lee I.-N.; CHIEN-HUNG CHEN; Sheu J.-C.; Lee H.-S.; Huang G.-T.; Yu C.-Y.; Lu F.-J.; Chow L.-P. |
| 臺大學術典藏 |
2022-02-23T02:12:38Z |
Hepatitis B- and C-related hepatocellular carcinomas yield different clinical features and prognosis
|
CHIEN-HUNG CHEN; Huang G.-T.; Yang P.-M.; Chen P.-J.; Lai M.-Y.; Chen D.-S.; Wang J.-D.; Sheu J.-C. |
| 臺大學術典藏 |
2022-02-23T02:12:37Z |
Identification of complement C3a as a candidate biomarker in human chronic hepatitis C and HCV-related hepatocellular carcinoma using a proteomics approach
|
Lee I.-N.; CHIEN-HUNG CHEN; Sheu J.-C.; Lee H.-S.; Huang G.-T.; Chen D.-S.; Yu C.-Y.; Wen C.-L.; Lu F.-J.; Chow L.-P. |
| 臺大學術典藏 |
2022-02-23T02:12:36Z |
Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants
|
CHIEN-HUNG CHEN; Yang P.-M.; Huang G.-T.; Lee H.-S.; Sung J.-L.; Sheu J.-C. |
| 臺大學術典藏 |
2022-02-23T02:12:35Z |
Differential DNA methylation associated with hepatitis B virus infection in hepatocellular carcinoma
|
Su P.-F.; Lee T.-C.; Lin P.-J.; Lee P.-H.; Jeng Y.-M.; CHIEN-HUNG CHEN; Liang J.-D.; Chiou L.-L.; Huang G.-T.; Lee H.-S. |
| 臺大學術典藏 |
2022-02-23T02:12:35Z |
Alterations of tumour suppressor gene PPP2R1B in hepatocellular carcinoma
|
Chou H.-C.; CHIEN-HUNG CHEN; Lee H.-S.; Lee C.-Z.; Huang G.-T.; Yang P.-M.; Lee P.-H.; Sheu J.-C. |
| 臺大學術典藏 |
2022-02-23T02:12:35Z |
Phenotypic analysis of tumor-infiltrating lymphocytes in hepatocellular carcinoma
|
CHIEN-HUNG CHEN; Lee H.-S.; Huang G.-T.; Yang P.-M.; Yu W.-A.; Cheng K.-C.; Lee P.-H.; Jeng Y.-M.; Chen D.-S.; Sheu J.-C. |
| 臺大學術典藏 |
2022-02-23T02:12:34Z |
Liver resection improves the survival of patients with multiple hepatocellular carcinomas
|
Ho M.-C.; Huang G.-T.; Tsang Y.-M.; Lee P.-H.; Chen D.-S.; Sheu J.-C.; CHIEN-HUNG CHEN |
| 臺大學術典藏 |
2022-02-23T02:12:34Z |
Clinical manifestations and survival of hepatocellular carcinoma patients with peritoneal metastasis
|
Lin C.-C.; Liang H.-P.; Lee H.-S.; Huang G.-T.; Yang P.-M.; Ho M.-C.; Lee P.-H.; Tsang Y.-M.; Chen D.-S.; Sheu J.-C.; CHIEN-HUNG CHEN |
| 臺大學術典藏 |
2022-02-23T02:12:33Z |
Global gene expression profiling reveals a key role of CD44 in hepatic oval-cell reaction after 2-AAF/CCl4 injury in rodents
|
Chiu C.-C.; Sheu J.-C.; CHIEN-HUNG CHEN; Lee C.-Z.; Chiou L.-L.; Chou S.-H.; Huang G.-T.; Lee H.-S. |
| 臺大學術典藏 |
2022-02-23T02:12:33Z |
Applicability of staging systems for patients with hepatocellular carcinoma is dependent on treatment method - Analysis of 2010 Taiwanese patients
|
CHIEN-HUNG CHEN; Hu F.-C.; Huang G.-T.; Lee P.-H.; Tsang Y.-M.; Cheng A.-L.; Chen D.-S.; Wang J.-D.; Sheu J.-C. |
| 臺大學術典藏 |
2022-02-23T02:12:32Z |
Clinical manifestations and survival of patients with hepatocellular carcinoma and cardiac metastasis
|
Liu Y.-C.; Ho Y.-L.; Huang G.-T.; Chen D.-S.; Sheu J.-C.; CHIEN-HUNG CHEN |
| 臺大學術典藏 |
2022-02-23T02:12:30Z |
Hepatocellular carcinoma with duodenal invasion and metastasis
|
Liang J.-D.; CHIEN-HUNG CHEN; Hsu S.-J.; Sheu J.-C.; Yang P.-M.; Lee H.-S.; Lee C.-Z.; Huang G.-T. |
| 臺大學術典藏 |
2022-02-23T02:12:24Z |
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Lu S.-N.; Wang J.-H.; Su C.-W.; Wang T.-E.; Dai C.-Y.; CHIEN-HUNG CHEN; Chen R.-C.; Yang S.-S.; Hung C.-F.; Huang S.-F.; Liao L.-Y.; Huo T.-I.; Wu C.-C.; Lee P.-H.; Ting C.-T.; Lee W.-C.; Chau G.-Y.; Wang C.-C.; Lee K.-T.; Huang Y.-H.; Ho M.-C.; Lin S.-M.; Huang G.-T.; Chen K.-Y.; Lin X.-Z.; Hwang J.-I.; Chiou Y.-Y.; Wang C.-K.; Hu J.-T.; Chen S.-C.; Liang P.-C.; Lee R.-C.; Wu D.-K.; Lin C.-Y.; Lin C.-C.; Cheng A.-L.; Hsu C.; Chao Y.; Chen L.-T.; Wang P.-M.; Wang P.-M.; Hong J.-H.; Hsu H.-C.; Chen S.-W.; Leung S.W.; Cheng J.C.-H.; Wu J.-C.; Wu C.-Y.; Hsu Y.-C.; Hsu C.-W.; Ni Y.-H.; Lin C.-L.; Local ablation group, Surveillance group, Diagnosis group, Staging group, Surgery group, TACE/TARE/HAI group, Target therapy/systemic therapy group, Radiotherapy group, Prevention group, Drafting group |
